Importance of cardiac imaging assessment of epicardial adipose tissue after a first episode of myocardial infarction
Loading...
Official URL
Full text at PDC
Publication date
2022
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Frontiers
Citation
Islas F, Gutiérrez E, Cachofeiro V, Martínez-Martínez E, Marín G, Olmos C, et al. Importance of cardiac imaging assessment of epicardial adipose tissue after a first episode of myocardial infarction. Front Cardiovasc Med 2022;9:995367. https://doi.org/10.3389/fcvm.2022.995367
Abstract
Background: Over the past years, information about the crosstalk between the
epicardial adipose tissue (EAT) and the cardiovascular system has emerged.
Notably, in the context of acute myocardial infarction (AMI), EAT might have
a potential role in the pathophysiology of ventricular structural changes and
function, and the clinical evolution of patients. This study aims to assess the
impact of EAT on morpho-functional changes in the left ventricle (LV) and the
outcome of patients after an AMI.
Methods: We studied prospectively admitted patients to our hospital
with a first episode of AMI. All patients underwent percutaneous coronary
intervention (PCI) during admission. Transthoracic echocardiography (TTE)
was performed within 24–48 h after PCI, as well as blood samples to assess
levels of galectin-3 (Gal-3). Cardiac magnetic resonance (CMR) was performed
5–7 days after PCI. Clinical follow-up was performed at 1 and 5 years after MI.
Results: Mean age of our cohort (n = 41) was 57.5 ± 10 years, and 38
(93%) were male. Nine patients had normal BMI, 15 had overweight (BMI
25–30), and 17 were obese (BMI > 30). Twenty three patients (56%) had ≥
4 mm thickness of EAT measured with echo. In these patients, baseline left
ventricular ejection fraction (LVEF) after AMI was significantly lower, as well as
global longitudinal strain. EAT thickness ≥ 4 m patients presented larger infarct
size, higher extracellular volume, and higher T1 times than patients with EAT
< 4 mm. As for Gal-3, the median was 16.5 ng/mL [12.7–25.2]. At five-year
follow-up 5 patients had major cardiac events, and all of them had EAT ≥ 4 mm.
Conclusions: Patients with EAT >4 mm have worse LVEF and GLS, larger infarct
size and longer T1 values after a MI, and higher levels of Gal-3. EAT >4 mm
was an independent predictor of MACE at 5-year follow-up. EAT thickness
is a feasible, noninvasive, low-cost parameter that might provide important
information regarding the chronic inflammatory process in the myocardium
after an infarction.












